PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company Reports2seventy Bio
2seventy Bio(TSVT)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Loading
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Plot placeholder
Mock data
Subscribe for the real data
Revenue by Drug
Loading
Marketed Drugs
No data
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Lornoxicam
neoplasms
,
lymphoma
,
precursor cell lymphoblastic leukemia-lymphoma
,
precursor t-cell lymphoblastic leukemia-lymphoma
,
multiple myeloma
,
plasma cell neoplasms
,
hodgkin disease
,
mantle-cell lymphoma
,
renal cell carcinoma
,
t-cell leukemia
,
b-cell leukemia
,
breast neoplasms
,
non-hodgkin lymphoma
,
leukemia
,
lymphoid leukemia
,
b-cell lymphoma
,
sarcoma
,
large b-cell lymphoma diffuse
,
non-small-cell lung carcinoma
,
neoplasm metastasis
,
osteosarcoma
,
b-cell chronic lymphocytic leukemia
,
osteoporosis
,
cerebrotendinous xanthomatosis
,
recurrence
,
follicular lymphoma
,
kidney diseases
Cc5013
carcinoma
,
neoplasms
,
adenoid cystic carcinoma
,
neuroendocrine tumors
,
b-cell lymphoma marginal zone
,
mantle-cell lymphoma
,
multiple myeloma
,
plasma cell neoplasms
,
lymphoma
,
leukemia
,
b-cell chronic lymphocytic leukemia
,
hodgkin disease
,
recurrence
,
non-hodgkin lymphoma
,
large b-cell lymphoma diffuse
,
b-cell lymphoma
,
follicular lymphoma
,
polycythemia vera
,
polycythemia
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use